Browse Hematology/Oncology Articles by Topic

Decisional Capacity Is Most Common Issue in Neuro-Oncologic Ethical Consults

For a terminal condition, goals of care need to be identified so they can be honored. If discussions do not happen early, when the patient likely is at his or her peak functional status, it leaves caregivers, families, and physicians with little guidance.

Left-Sided Breast Cancer Radiation Therapy and Coronary Artery Disease

A study of breast cancer survivors revealed left breast radiation therapy doubles the subsequent risk of coronary heart disease vs. right-sided radiation.

Emergency Care Improvement Needed for Patients with Sickle Cell Disease

Every patient with sickle cell disease (SCD) should be evaluated by an expert in SCD care who can develop a patient-specific treatment plan that can be used in the ED. Without such a resource, caring for SCD patients will continue to be challenging for emergency providers.

Mammograms as a Cardiometabolic Disease Prevention Tool

In a study of women undergoing routine mammographic screening for breast cancer, mammographic features, such as microcalcifications and breast density, were associated with the risk of developing cardiovascular disease.

Using Cardiac MRI to Detect Suspected Tumors

Among patients with suspected cardiac tumors, cardiac MRI was highly accurate at distinguishing tumor from thrombus and benign from malignant tumors, using subsequent clinical data over five years of follow-up as the diagnostic standard.

Can Antibiotics Lead to Colon Cancer?

Swedish researchers saw an association between frequent antibiotic use and proximal colorectal cancer.

Jury Still Out on Convalescent Plasma

One year after the FDA issued an emergency use authorization, investigators are struggling to draw firm conclusions about the efficacy of this solution against COVID-19.

Iron Therapy for Acute Heart Failure

Giving intravenous ferric carboxymaltose to stabilized post-acute heart failure patients with iron deficiency improved quality of life vs. placebo-treated patients within four weeks, which persisted during subsequent therapy for up to 24 weeks.

Pegcetacoplan Injection (Empaveli)

The FDA has approved a new treatment for paroxysmal nocturnal hemoglobinuria, a rare, life-threatening blood disease.

Predicting Coronary Artery Disease in Breast Cancer Patients

The authors applied an automated algorithm to calculate an Agatston coronary artery calcium score from non-ECG-gated planning CT scans in breast cancer patients undergoing radiation therapy. This provided a graded risk calculation that could encourage preventive measures in patients at highest risk of a cardiovascular disease event.